ALNY – Alnylam Pharmaceuticals, Inc. –

  • Quotes
  • Charts

News & Analysis for ALNY

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Files An 8-K Entry into a Material...

ME Staff 8-k -
0

Insider Trading Activity Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) – SVP Sold 43,750...

ME Staff -
0

Insider Trading Activity Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) – VP Sold 9,375...

ME Staff -
0

Analyst Activity – Leerink Swann Reiterates Market Perform on Alnylam Pharmaceuticals...

ME Staff -
0

Analyst Activity – Cowen and Company Reiterates Outperform on Alnylam Pharmaceuticals...

ME Staff -
0

Analyst Activity – Chardan Capital Lowers Its Price Target On Alnylam...

ME Staff -
0

Analyst Activity – Credit Suisse Group AG Reiterates Hold on Alnylam...

ME Staff -
0

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Files An 8-K Departure of Directors or...

ME Staff 8-k -
0

Analyst Activity – Credit Suisse Group AG Reiterates Hold on Alnylam...

ME Staff -
0

Analyst Activity – Morgan Stanley Reiterates Equal Weight on Alnylam Pharmaceuticals...

ME Staff -
0

Analyst Activity – Chardan Capital Reiterates Buy on Alnylam Pharmaceuticals (NASDAQ:ALNY)

ME Staff -
0

Analyst Activity – Chardan Capital Reiterates Buy on Alnylam Pharmaceuticals (NASDAQ:ALNY)

ME Staff -
0

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported earnings of ($1.25) per share beating...

ME Staff -
0

Alnylam ...

ME Staff 8-k -
0

Analyst Activity – BMO Capital Markets Initiates Coverage On Alnylam Pharmaceuticals...

ME Staff -
0

Analyst Activity – FBR & Co Reiterates Buy on Alnylam Pharmaceuticals...

ME Staff -
0

Analyst Activity – FBR & Co Reiterates Buy on Alnylam Pharmaceuticals...

ME Staff -
0

Insider Trading Activity Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) – Director Sold 15,000...

ME Staff -
0
Load more